HTHT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HTHT is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The stock has constructive analyst support and a decent pre-market setup, but the technical trend is still mixed and the latest signal stack does not justify an aggressive buy today. If you are impatient and want an immediate decision, the better call is to hold off rather than chase it at this price.
HTHT is trading at 44.76 in pre-market, very close to pivot support at 44.593. Momentum is mildly improving because the MACD histogram is positive and expanding, but RSI at 44.65 remains neutral, not oversold enough to signal a compelling entry. The moving averages are still bearish with SMA_200 > SMA_20 > SMA_5, which means the broader trend has not fully turned up yet. Resistance is nearby at 46.224 and 47.232, while support sits at 42.962 and 41.954. Overall, the chart shows an early rebound attempt, but not a confirmed long-term breakout.
["Citi kept a Buy rating and added an upside 30-day catalyst watch, expecting decent RevPAR trends to continue into the upcoming Labor Day holiday.", "Benchmark raised its target to $60 from $52 and reiterated Buy after solid Q4 results and a more constructive outlook.", "Macquarie lifted its target to $62 from $59, citing strong Q4 revenue and EBITDA growth, improving RevPAR recovery, and continued margin expansion from the asset-light strategy.", "UBS upgraded the stock to Buy and raised its target to $62.40, citing mix improvement, higher margin expectations, and valuation below global peers.", "China manufacturing PMI improved to 51.8, which is supportive for domestic economic activity and travel-related demand."]
["The broader technical trend is still bearish on moving averages, suggesting the recovery is not yet confirmed.", "RSI is only neutral, so the stock is not showing strong breakout momentum.", "Hedge funds and insiders are both neutral with no significant recent accumulation trends.", "No recent congress trading data is available.", "The stock trend model suggests only a modest next-week move and a negative next-month expectation."]
Latest quarter financials are not fully available because the financial snapshot data errored out. However, analyst commentary on the most recent quarter was positive: Q4 revenue rose 8.3% year over year and adjusted EBITDA rose 83% year over year, both beating consensus. Analysts also cited RevPAR recovery, overseas RevPAR up 7.4% year over year, and margin expansion from the asset-light strategy. Guidance also pointed to about 1,600 new hotel openings in 2026 and revenue growth of 2%-6% year over year.
Analyst sentiment has improved meaningfully over the last few months. Citi, Benchmark, Macquarie, and UBS all remain positive, with Citi maintaining Buy and adding a 30-day catalyst watch, while Benchmark, Macquarie, and UBS raised price targets into the $60-$62.40 range. The Wall Street pros view is bullish overall: they like RevPAR recovery, margin expansion, new hotel openings, and attractive valuation versus peers. The main con is that the stock still needs cleaner technical confirmation before it becomes a high-conviction entry for a long-term beginner.
